Corimmun Overview

  • Founded
  • 2006
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Corimmun General Information

Description

Developer of therapeutics for the treatment of cardiovascular diseases. The company produces medication for cardiovascular diseases with unmet medical need.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Janssen-Cilag
Primary Office
  • Lochhamer Street 29
  • Rückgebäude
  • 82152 Martinsried
  • Germany
+49 00000000000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Corimmun Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 28-Jun-2012 000.00 Completed Generating Revenue
4. Early Stage VC (Series B) 01-Oct-2010 00.00 000.00 Completed Generating Revenue
3. Grant 05-Jul-2010 00.000 00.000 Completed
2. Early Stage VC (Series A) 22-Aug-2008 $7.59M $8.48M Completed Product Development
1. Seed Round 01-Jan-2007 $897K $897K Completed Startup
To view Corimmun’s complete valuation and funding history, request access »

Corimmun Executive Team (3)

Name Title Board Seat Contact Info
Götz Münch Co-Founder and Chief Executive Officer
Martin Ungerer Chief Medical Officer and Co-Founder
You’re viewing 2 of 3 executive team members. Get the full list »

Corimmun Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bayern Kapital Venture Capital Minority 000 0000 000000 0
BioM Biotech Cluster Development Accelerator/Incubator Minority 000 0000 000000 0
Global Chance Fund Venture Capital Minority 000 0000 000000 0
High-Tech Gründerfonds Venture Capital Minority 000 0000 000000 0
KfW Group Investment Bank Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Corimmun Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 01-Jan-2007 000000000 Other Healthcare Technology Systems
To view Corimmun’s complete investments history, request access »